NDC Package 60505-0813-1 Butorphanol Tartrate

Spray Nasal - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
60505-0813-1
Package Description:
1 BOTTLE, SPRAY in 1 CONTAINER / 2.5 mL in 1 BOTTLE, SPRAY
Product Code:
Proprietary Name:
Butorphanol Tartrate
Non-Proprietary Name:
Butorphanol Tartrate
Substance Name:
Butorphanol Tartrate
Usage Information:
This medication is used to treat moderate to severe pain, including pain from surgery, muscle pain, and migraine headaches. Butorphanol is an opioid pain reliever similar to morphine. It acts on certain centers in the brain to give you pain relief. Butorphanol can also block the effects of opioids and can cause withdrawal symptoms in people dependent on opioids. If possible, people who have recently used opioids in high doses or for a long time should not use butorphanol. (See also Side Effects section.)
11-Digit NDC Billing Format:
60505081301
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 886634 - butorphanol tartrate 10 MG/mL Metered Dose Nasal Spray
  • RxCUI: 886634 - butorphanol tartrate 1 MG/ACTUAT Metered Dose Nasal Spray
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Apotex Corp.
    Dosage Form:
    Spray - A liquid minutely divided as by a jet of air or steam.
    Administration Route(s):
  • Nasal - Administration to the nose; administered by way of the nose.
  • Active Ingredient(s):
    DEA Schedule:
    Schedule IV (CIV) Substances
    Sample Package:
    No
    FDA Application Number:
    ANDA075499
    Marketing Category:
    ANDA - A product marketed under an approved Abbreviated New Drug Application.
    Start Marketing Date:
    12-04-2002
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 60505-0813-1?

    The NDC Packaged Code 60505-0813-1 is assigned to a package of 1 bottle, spray in 1 container / 2.5 ml in 1 bottle, spray of Butorphanol Tartrate, a human prescription drug labeled by Apotex Corp.. The product's dosage form is spray and is administered via nasal form.

    Is NDC 60505-0813 included in the NDC Directory?

    Yes, Butorphanol Tartrate with product code 60505-0813 is active and included in the NDC Directory. The product was first marketed by Apotex Corp. on December 04, 2002 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 60505-0813-1?

    The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

    What is the 11-digit format for NDC 60505-0813-1?

    The 11-digit format is 60505081301. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-160505-0813-15-4-260505-0813-01